Your browser doesn't support javascript.
loading
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
Arribas, José R; Girard, Pierre-Marie; Landman, Roland; Pich, Judit; Mallolas, Josep; Martínez-Rebollar, María; Zamora, Francisco X; Estrada, Vicente; Crespo, Manuel; Podzamczer, Daniel; Portilla, Joaquín; Dronda, Fernando; Iribarren, José A; Domingo, Pere; Pulido, Federico; Montero, Marta; Knobel, Hernando; Cabié, André; Weiss, Laurence; Gatell, José M.
Affiliation
  • Arribas JR; Hospital La Paz, Instituto de Investigation Sanitaria del Hospital Universitario La Paz, Madrid, Spain. Electronic address: joser.arribas@salud.madrid.org.
  • Girard PM; Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale UMR_S 1136, Paris, France.
  • Landman R; Hôpital Bichat-Claude Bernard, AP-HP, and Institut National de la Santé et de la Recherche Médicale UMR 1137, Paris, France.
  • Pich J; Hospital Clínic/Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Mallolas J; Hospital Clínic/Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Martínez-Rebollar M; Hospital Clínic/Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Zamora FX; Hospital La Paz, Instituto de Investigation Sanitaria del Hospital Universitario La Paz, Madrid, Spain.
  • Estrada V; Hospital Clínico San Carlos, Madrid, Spain.
  • Crespo M; Hospital Vall d'Hebrón, Barcelona, Spain.
  • Podzamczer D; Hospital Universitario de Bellvitge, Barcelona, Spain.
  • Portilla J; Hospital General Universitario de Alicante, Alicante, Spain.
  • Dronda F; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Iribarren JA; Hospital de Donostia, Donostia, Spain.
  • Domingo P; Hospital de Sant Pau, Barcelona, Spain.
  • Pulido F; Hospital Universitario Doce de Octubre, i+12, Madrid, Spain.
  • Montero M; Hospital La Fe, Valencia, Spain.
  • Knobel H; Hospital del Mar, Barcelona, Spain.
  • Cabié A; CHU de Martinique-Institut National de la Santé et de la Recherche Médicale CIC1224, Fort-de-France, France.
  • Weiss L; Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, and Université Paris Descartes, Sorbonne Paris-Cité, Paris, France.
  • Gatell JM; Hospital Clínic/Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
Lancet Infect Dis ; 15(7): 785-92, 2015 Jul.
Article in En | MEDLINE | ID: mdl-26062880
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / HIV Infections / HIV-1 / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2015 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / HIV Infections / HIV-1 / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors / Anti-HIV Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2015 Document type: Article Country of publication: